Ann Dermatol.  2014 Oct;26(5):669-670. 10.5021/ad.2014.26.5.669.

Injection-Site Reaction Following 5-Azacitidine Injection

• Jun HJ
• Ko HR
• Lee JY
• Lee YB
• Kim JW
• Yu DS

• KMID: 2265521
• DOI: http://doi.org/10.5021/ad.2014.26.5.669

Abstract

No abstract available.

Figure

• 

  Fig. 1 An ecchymotic erythematous patch with bulla is visible on the abdomen where the 5-azacitidine was injected.

Reference

1. Keating GM. Azacitidine: a review of its use in higher-risk myelodysplastic syndromes/acute myeloid leukaemia. Drugs. 2009; 69:2501–2518.

2. Santini V, Fenaux P, Mufti GJ, Hellström-Lindberg E, Silverman LR, List A, et al. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine. Eur J Haematol. 2010; 85:130–138.

3. Guarneri C, Polimeni G. Nicolau syndrome following etanercept administration. Am J Clin Dermatol. 2010; 11:Suppl 1. 51–52.

4. Faucher L, Marcoux D. What syndrome is this? Nicolau syndrome. Pediatr Dermatol. 1995; 12:187–190.